![](http://cardiovascularpharmacology.org/wp-content/uploads/2022/03/Lother_KIS2022-780x439.jpg)
Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms
MR antagonists have proven to be highly efficient in patients with heart failure and reduced ejection fraction, and they are a cornerstone of contemporary therapy. In the past decade, a series of experimental studies using models with cell type–specific MRs uncovered the more…